By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Chemin Messidor 5-7
Case Postale 5911
Lausanne    CH - 1002  Switzerland
Phone: 41-21-321-0111 Fax: 41-21-321-0169


Company News
Debiopharm Dumps Double Digit Millions Into Canadian Startup GenePOC 8/30/2016 9:44:49 AM
Debiopharm Initiates Clinical Phase II Study Evaluating Debio 1143 In Ovarian Cancer 6/7/2016 10:23:02 AM
FDA Grants Orphan Drug Designation To Debiopharms IAP Inhibitor Debio 1143 In The Treatment Of Ovarian Cancer 6/2/2016 6:32:01 AM
Debiopharm Donates To IMD To Promote Best Practice In Family Business Philanthropy 5/11/2016 9:10:35 AM
Debiopharm Announces Presentation At AACR Of Non-Clinical Data Relating To Its Targeted Investigational Compound Debio 1347/CH5183284, A Selective FGFR 1,2,3 Inhibitor 4/15/2016 8:14:27 AM
Debiopharm To Present The Latest Findings On Debio 1450 At ECCMID 4/8/2016 11:07:20 AM
Debiopharm Has Won Its Patent Infringement Suit For Elplat Against Nippon Kayaku Co., Ltd. 3/4/2016 6:30:25 AM
Debiopharm And EORTC Announce A Collaboration To Investigate Triptorelin For Treatment Of Salivary Gland Cancers 1/13/2016 9:36:29 AM
United Laboratories Inc. And Debiopharm Announce The Launch Of Pamorelin LA In The Philippines 12/7/2015 7:38:37 AM
Debiopharm's Partner Yakult Honsha Announces Elplat Approbation In Gastric Cancer In Japan 11/24/2015 6:41:16 AM